WGS FY 2021 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

FY 2021 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$212M+18.3% YoY

Gross Profit

-$17M-7.8% margin

Operating Income

-$446M-210.3% margin

Net Income

-$245M-115.6% margin

EPS (Diluted)

$-74.93

Cash Flow

Operating Cash Flow

-$190M

Free Cash Flow

-$211M

Stock-Based Comp.

$219M

Balance Sheet

Total Assets

$554M

Total Liabilities

$166M

Stockholders' Equity

$388M

Cash & Equivalents

$401M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$212M	$179M	+18.3%
Gross Profit	-$17M	$4M	-512.4%
Operating Income	-$446M	-$242M	-84.4%
Net Income	-$245M	-$241M	-1.7%